Proposed Data Collections Submitted for Public Comment and Recommendations, 5660-5661 [E9-2006]
Download as PDF
<![CDATA[
5660
Federal Register / Vol. 74, No. 19 / Friday, January 30, 2009 / Notices
Health Nurses (AAOHN), and the
American Society of Safety Engineers
(ASSE). There is no cost to respondents.
The estimated annualized burden hours
are 205.
ESTIMATED ANNUALIZED BURDEN HOURS:
Number of
respondents
Form name
Type of respondent
NIOSH Customer Satisfaction Survey ..................
Average
burden per
response
(in hours)
570
150
1
1
20/60
6/60
Respondents familiar with NIOSH .......................
Respondents not familiar with NIOSH .................
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–2005 Filed 1–29–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-09–0234]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
mstockstill on PROD1PC66 with NOTICES
Number of
responses
per
respondent
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call the CDC Reports
Clearance Officer at 404–639–5960 or
send comments to CDC/ATSDR
Assistant Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
VerDate Nov<24>2008
16:54 Jan 29, 2009
Jkt 217001
Proposed Project
National Ambulatory Medical Care
Survey (NAMCS) (OMB No. 0920–
0234)—Revision—National Center for
Health Statistics (NCHS), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Section 306 of the Public Health
Service (PHS) Act (42 U.S.C. 242k), as
amended, authorizes that the Secretary
of Health and Human Services (DHHS),
acting through NCHS, shall collect
statistics on ‘‘utilization of health care’’
in the United States. NAMCS was
conducted annually from 1973 to 1981,
again in 1985, and resumed as an
annual survey in 1989. The purpose of
NAMCS is to meet the needs and
demands for statistical information
about the provision of ambulatory
medical care services in the United
States. NCHS is seeking OMB approval
to extend this survey for three years.
Ambulatory services are rendered in a
wide variety of settings, including
physician offices and hospital
outpatient and emergency departments.
The NAMCS target universe consists of
all office visits made by ambulatory
patients to non-Federal office-based
physicians (excluding those in the
specialties of anesthesiology, radiology,
and pathology) who are engaged in
direct patient care.
In 2006, physicians and mid-level
providers (i.e., nurse practitioners,
physician assistants, and nurse
midwives) practicing in community
health centers (CHCs) were added to the
NAMCS sample, and these data will
continue to be collected. To
complement NAMCS data, NCHS
initiated the National Hospital
Ambulatory Medical Care Survey
(NHAMCS, OMB No. 0920–0278) in
1992 to provide data concerning patient
visits to hospital outpatient and
emergency departments. NAMCS and
NHAMCS are the principal sources of
data on ambulatory care provided in the
United States.
NAMCS provides a range of baseline
data on the characteristics of the users
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
and providers of ambulatory medical
care. Data collected include the patients’
demographic characteristics, reason(s)
for visit, provider diagnoses, diagnostic
services, medications, and visit
disposition. In addition, information on
cervical cancer screening practices in
physician offices will continue to be
collected through the Cervical Cancer
Screening Supplement (CCSS), which
was added in 2006. It will allow CDC’s
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP) to evaluate cervical cancer
screening methods and the use of
Human Papillomavirus DNA tests.
A supplemental mail survey on the
adoption and use of electronic medical
records (EMRs) in physician offices was
added to NAMCS in 2008, and will
continue. These data were requested by
the Office of the National Coordinator
for Health Information Technology
(ONC), Department of Health and
Human Services, to measure progress
toward goals for EMR adoption. The
mail survey will collect information on
characteristics of physician practices
and the capabilities of EMRs used in
those practices.
In 2009, NAMCS will include an
additional sample of 70 physicians to
pretest additional questionnaire items
on laboratory values. These new items
were requested by the Division of Heart
Disease and Stroke Prevention within
NCCDPHP to better understand the
extent to which ambulatory health care
providers identify and control abnormal
values before and after cardiovascular
disease.
Users of NAMCS data include, but are
not limited to, Congressional offices,
Federal agencies, state and local
governments, schools of public health,
colleges and universities, private
industry, nonprofit foundations,
professional associations, clinicians,
researchers, administrators, and health
planners.
There is no cost to respondents other
than their time to participate.
E:\FR\FM\30JAN1.SGM
30JAN1
5661
Federal Register / Vol. 74, No. 19 / Friday, January 30, 2009 / Notices
ESTIMATED ANNUALIZED BURDEN TABLE
Number of
respondents
Form
Number of
responses per
respondent
Average
burden per
response
(in hrs)
Total burden
hours
Induction Interview—Physicians/CHC Providers .............................................
Patient Record Form .......................................................................................
CCSS ...............................................................................................................
EMR Mail Survey .............................................................................................
CHC Induction Interview—Facility ...................................................................
3,480
1,388
464
1,143
104
1
30
1
1
1
28/60
6/60
15/60
16/60
18/60
1,624
4,164
116
305
31
Total ..........................................................................................................
........................
........................
........................
6,240
Dated: January 23, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Office of
the Chief Science Officer, Centers for Disease
Control and Prevention.
[FR Doc. E9–2006 Filed 1–29–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
mstockstill on PROD1PC66 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Immunology
Integrated Review Group; Vaccines Against
Microbial Diseases Study Section.
Date: February 5, 2009.
Time: 8 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westin St. Francis, 335 Powell
Street, San Francisco, CA 94102.
Contact Person: Jian Wang, MD, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4218,
MSC 7812, Bethesda, MD 20892, (301) 435–
2778, wangjia@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
VerDate Nov<24>2008
16:54 Jan 29, 2009
Jkt 217001
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group; Genetics
of Health and Disease Study Section.
Date: February 5–6, 2009.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Cheryl M. Corsaro, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2204,
MSC 7890, Bethesda, MD 20892, (301) 435–
1045, corsaroc@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Child
Psychopathology.
Date: February 9, 2009.
Time: 10 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: Serrano Hotel, 405 Taylor Street,
San Francisco, CA 94102.
Contact Person: Dana Jeffrey Plude, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3176,
MSC 7848, Bethesda, MD 20892, (301) 435–
2309, pluded@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Metabolic
Endocrinology.
Date: February 11–12, 2009.
Time: 8 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Reed A. Graves, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6166,
MSC 7892, Bethesda, MD 20892, (301) 402–
6297, gravesr@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Gene
Therapy Member Conflict.
Date: February 11, 2009.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Syed M. Quadri, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6210,
MSC 7804, Bethesda, MD 20892, 301–435–
1211, quadris@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Hematopoietic Stem Cell Regulation.
Date: February 12, 2009.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Bukhtiar H. Shah, DVM,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4120,
MSC 7802, Bethesda, MD 20892, (301) 435–
1233, shahb@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 22, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–1845 Filed 1–29–09; 8:45 am]
BILLING CODE 4140–01–M
E:\FR\FM\30JAN1.SGM
30JAN1
]]>Agencies
[Federal Register Volume 74, Number 19 (Friday, January 30, 2009)]
[Notices]
[Pages 5660-5661]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-2006]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-09-0234]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call the CDC Reports
Clearance Officer at 404-639-5960 or send comments to CDC/ATSDR
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D74,
Atlanta, GA 30333 or send an e-mail to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
National Ambulatory Medical Care Survey (NAMCS) (OMB No. 0920-
0234)--Revision--National Center for Health Statistics (NCHS), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
Section 306 of the Public Health Service (PHS) Act (42 U.S.C.
242k), as amended, authorizes that the Secretary of Health and Human
Services (DHHS), acting through NCHS, shall collect statistics on
``utilization of health care'' in the United States. NAMCS was
conducted annually from 1973 to 1981, again in 1985, and resumed as an
annual survey in 1989. The purpose of NAMCS is to meet the needs and
demands for statistical information about the provision of ambulatory
medical care services in the United States. NCHS is seeking OMB
approval to extend this survey for three years.
Ambulatory services are rendered in a wide variety of settings,
including physician offices and hospital outpatient and emergency
departments. The NAMCS target universe consists of all office visits
made by ambulatory patients to non-Federal office-based physicians
(excluding those in the specialties of anesthesiology, radiology, and
pathology) who are engaged in direct patient care.
In 2006, physicians and mid-level providers (i.e., nurse
practitioners, physician assistants, and nurse midwives) practicing in
community health centers (CHCs) were added to the NAMCS sample, and
these data will continue to be collected. To complement NAMCS data,
NCHS initiated the National Hospital Ambulatory Medical Care Survey
(NHAMCS, OMB No. 0920-0278) in 1992 to provide data concerning patient
visits to hospital outpatient and emergency departments. NAMCS and
NHAMCS are the principal sources of data on ambulatory care provided in
the United States.
NAMCS provides a range of baseline data on the characteristics of
the users and providers of ambulatory medical care. Data collected
include the patients' demographic characteristics, reason(s) for visit,
provider diagnoses, diagnostic services, medications, and visit
disposition. In addition, information on cervical cancer screening
practices in physician offices will continue to be collected through
the Cervical Cancer Screening Supplement (CCSS), which was added in
2006. It will allow CDC's National Center for Chronic Disease
Prevention and Health Promotion (NCCDPHP) to evaluate cervical cancer
screening methods and the use of Human Papillomavirus DNA tests.
A supplemental mail survey on the adoption and use of electronic
medical records (EMRs) in physician offices was added to NAMCS in 2008,
and will continue. These data were requested by the Office of the
National Coordinator for Health Information Technology (ONC),
Department of Health and Human Services, to measure progress toward
goals for EMR adoption. The mail survey will collect information on
characteristics of physician practices and the capabilities of EMRs
used in those practices.
In 2009, NAMCS will include an additional sample of 70 physicians
to pretest additional questionnaire items on laboratory values. These
new items were requested by the Division of Heart Disease and Stroke
Prevention within NCCDPHP to better understand the extent to which
ambulatory health care providers identify and control abnormal values
before and after cardiovascular disease.
Users of NAMCS data include, but are not limited to, Congressional
offices, Federal agencies, state and local governments, schools of
public health, colleges and universities, private industry, nonprofit
foundations, professional associations, clinicians, researchers,
administrators, and health planners.
There is no cost to respondents other than their time to
participate.
[[Page 5661]]
Estimated Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Form respondents responses per response (in hours
respondent hrs)
----------------------------------------------------------------------------------------------------------------
Induction Interview--Physicians/CHC Providers... 3,480 1 28/60 1,624
Patient Record Form............................. 1,388 30 6/60 4,164
CCSS............................................ 464 1 15/60 116
EMR Mail Survey................................. 1,143 1 16/60 305
CHC Induction Interview--Facility............... 104 1 18/60 31
---------------------------------------------------------------
Total....................................... .............. .............. .............. 6,240
----------------------------------------------------------------------------------------------------------------
Dated: January 23, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Office of the Chief Science Officer,
Centers for Disease Control and Prevention.1
[FR Doc. E9-2006 Filed 1-29-09; 8:45 am]
BILLING CODE 4163-18-P
